A comprehensive view of Journal of the American Medical Association JAMA. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA to discuss Eli Lilly's Alzheimer's treatment, donanemab, at advisory committee meeting; results from phase 3 trial have been published in the Journal of the American Medical Assn.

Obesity patients regain weight after quitting Eli Lilly's drug Zepbound, suggests a study published in the Journal of the American Medical Assn., study finds patients lost an average of 20.9% of body weight while on drug, regained 14% after stopping drug

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count